Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy

2020 ◽  
Vol 35 (5) ◽  
pp. 825-832 ◽  
Author(s):  
Miyeong Gang ◽  
Toru Baba ◽  
Yoshiyuki Hosokai ◽  
Yoshiyuki Nishio ◽  
Akio Kikuchi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Basal Forebrain ◽  
Metabolic Changes

scholarly journals Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

2020 ◽  
Vol 139 ◽  
pp. 104831 ◽  
Author(s):  
Joana B. Pereira ◽  
Sara Hall ◽  
Mattis Jalakas ◽  
Michel J. Grothe ◽  
Olof Strandberg ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Basal Forebrain

PET-MRI analysis to identify metabolic changes during Parkinson's disease

2021 ◽  
Author(s):  
Adair Valdivia Vargas ◽  
Briant Moreno Abad ◽  
Raquel Valdés Cristerna ◽  
Carlos Cardeña Arredondo ◽  
Carlos Aguilar Palomeque ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Metabolic Changes

Assessment of metabolic changes in the striatum of a MPTP-intoxicated canine model: in vivo 1H-MRS study of an animal model for Parkinson's disease

2011 ◽  
Vol 29 (1) ◽  
pp. 32-39 ◽  
Author(s):  
Chi-Bong Choi ◽  
Sang-Young Kim ◽  
Sung-Ho Lee ◽  
Geon-Ho Jahng ◽  
Hwi-Yool Kim ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Animal Model ◽  
Canine Model ◽  
Metabolic Changes ◽  
1H Mrs

scholarly journals Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease

2018 ◽  
Vol 34 (4) ◽  
pp. 516-525 ◽  
Author(s):  
Fatma Gargouri ◽  
Cécile Gallea ◽  
Marie Mongin ◽  
Nadya Pyatigorskaya ◽  
Romain Valabregue ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Magnetic Resonance ◽  
Cognitive Deficits ◽  
Basal Forebrain ◽  
Resonance Imaging

Study of BDE-47 induced Parkinson’s disease-like metabolic changes in C57BL/6 mice by integrated metabolomic, lipidomic and proteomic analysis

2019 ◽  
Vol 378 ◽  
pp. 120738 ◽  
Author(s):  
Fenfen Ji ◽  
Sravan Gopalkrishnashetty Sreenivasmurthy ◽  
Juntong Wei ◽  
Xiaojian Shao ◽  
Hemi Luan ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Proteomic Analysis ◽  
Metabolic Changes

The NGF superfamily of neurotrophins: Potential treatment for Alzheimer's and Parkinson's disease

1995 ◽  
Vol 18 (1) ◽  
pp. 63-65 ◽  
Author(s):  
Elliott J. Mufson ◽  
Teresa Sobreviela
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Basal Forebrain ◽  
Tyrosine Kinase Receptors ◽  
Potential Treatment ◽  
Neuron Degeneration ◽  
Cholinergic Basal Forebrain ◽  
The Family ◽  
Substantia Nigra Neuron ◽  
Tissue Grafts

AbstractStein & Glasier suggest embryonic neural tissue grafts as a potential treatment strategy for Alzheimer's and Parkinson's disease. As an alternative, we suggest that the family of nerve growth factor-related neurotrophins and their trk (tyrosine kinase) receptors underlie cholinergic basal forebrain (CBF) and dopaminergic substantia nigra neuron degeneration in these diseases, respectively. Therefore, treatment approaches for these disorders could utilize neurotrophins.

Sign in / Sign up

Export Citation Format

Share Document